Keurig Dr Pepper Reaffirms 2025 Financial Growth Projections, Sets Mid-Single Digit Net Sales Growth

Keurig Dr Pepper has reaffirmed its financial growth projections for fiscal year 2025, expecting net sales to grow at a mid-single-digit pace in constant currency terms and adjusted diluted EPS to increase at a high-single-digit rate. Analysts project EPS to reach $2.04 and revenue to reach $16.16 billion. The average target price for Keurig Dr Pepper is $38.81, indicating an upside of 15.84% from the current price.

Keurig Dr Pepper Inc. (NASDAQ: KDP) has reaffirmed its financial growth projections for fiscal year 2025, expecting net sales to grow at a mid-single-digit pace in constant currency terms and adjusted diluted EPS to increase at a high-single-digit rate. The company reported strong Q2 2025 results, driven by healthy top-line growth and cost discipline momentum in U.S. Refreshment Beverages and International, with improving U.S. Coffee trends.

The company's Q2 2025 net sales increased by 6.1% to $4.2 billion, with a 7.2% increase on a constant currency basis. This growth was driven by volume/mix growth of 5.0% and favorable net price realization of 2.2%. The acquisition of GHOST contributed 4.0 percentage points to volume/mix growth. GAAP operating income increased by 4.3% to $898 million, while adjusted operating income rose by 7.0% to $1,028 million, totaling 24.7% of net sales.

The company's CEO, Tim Cofer, stated, "Our Q2 results cemented a strong first half of the year, as we drove robust performance in U.S. Refreshment Beverages, good growth in International, and sequential progress in U.S. Coffee. Though the back half will present new challenges, we are on track to deliver our 2025 outlook and are confident in the long-term value creation ahead."

Analysts project EPS to reach $2.04 and revenue to reach $16.16 billion. The average target price for Keurig Dr Pepper is $38.81, indicating an upside of 15.84% from the current price.

References:

[1] https://news.keurigdrpepper.com/2025-07-24-Keurig-Dr-Pepper-Reports-Q2-2025-Results-and-Reaffirms-Guidance-for-2025